Mosaic Ultra Bioprosthesis  Valve 

The Mosaic bioprosthesis – based on more than 30 years of Medtronic tissue valve design expertise – is an excellent choice for surgeons looking for long-lasting durability, exceptional performance and implantability for aortic, mitral and MICS procedures.

The Mosaic bioprosthesis is for the replacement of malfunctioning native or prosthetic aortic and/or mitral heart valves.

PRODUCT DETAILS

UNDENIABLY DURABLE.

Published clinical experience demonstrates impressive long-term performance in all age groups.

Additional factors that may contribute to durability are:

• Proprietary AOA anti-calcification tissue treatment that mitigates calcification and protects the tissue
• Next generation flexible polymer stent allows for absorption of stress produced during the cardiac cycle
• The Medtronic Physiologic Fixation^پ process minimizes the stress applied to the leaflets during tissue fixation

EXCELLENT CLINICAL OUTCOMES

EASE OF IMPLANT

Our innovative Cinch implant system further capitalizes on the valve’s flexible stent to facilitate valve implantation, particularly through a tight sinotubular space.

It also:

• Improves overall visualization
• Has stent posts that deflect to allow for easier knot tying near the posts in aortic replacements
• Helps prevent suture looping
• Facilitates minimally invasive procedures
• Protects tissue from inadvertent damage

ADVANCED TISSUE FIXATION

Our exclusive Physiologic Fixation process mitigates biomechanical failures and promotes long-term valve durability by:

• Improved preservation of valve structure and leaflet function, allowing it to function similar to a native valve
• Allowing leaflets to remain soft and flexible which protects the tissue from cyclic fatigue

SUITABILITY FOR FUTURE INTERVENTIONS

Valve dimensions and geometry facilitate future TAV-in-SAV replacements. This includes:

• Radiopaque stent post eyelets, which provide visible coaxial markers during TAV-in-SAV procedures
• MR conditional, non-metallic frame mitigates risk of corrosion between SAV and TAV stent materials
• Interior-mounted leaflets mitigate potential risk of coronary obstruction